Charleigh J. Granade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Charleigh J. Granade has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Megan C. Lindley
Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
3 shared publicationsAlexandra A. Bhatti
Public Health Law Program, Center for State, Tribal, Local, and Territorial Support, Centers for Disease Control and Prevention, Atlanta, Georgia; Cherokee Nation Assurance, Arlington, Virginia (5)Merck & Co., Inc, Kenilworth, New Jersey; Merck & Co., Inc, Kenilworth, New Jersey
2 shared publicationsRussell F. McCord
Public Health Law Program, Center for State, Tribal, Local, and Territorial Support, Centers for Disease Control and Prevention, Atlanta, Georgia; Cherokee Nation Assurance, Arlington, Virginia (5)Merck & Co., Inc, Kenilworth, New Jersey
2 shared publicationsAmimah Asif
Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States
1 shared publicationAmimah F. Asif
Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
1 shared publication- Amy Parker Fiebelkorn
Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H24-4, Atlanta, GA 30326, United States
1 shared publication
Latest Publications
- 19 March 2024
- Published by SAGE Publications in Public Health Reports®
- Vol. 139 (5) , 626-634
Analysis of the Federal Section 317 Immunization Program and Routine Adult Immunization Activities, United States, 2022-2023
Objectives: The federal Section 317 Immunization Program, administered by the Centers for Disease Control and Prevention (CDC), provides funding to support adult immunization efforts; however, current information on program implementation at the jurisdictional level is limited. We assessed the use of Section 317 and other funding sources to support routine adult immunization activities among the 64 immunization programs (“awardees”). Methods: We conducted a survey and key informant interviews with awardees in October to December 2022 to collect quantitative and qualitative data on current adult vaccine purchase and program operation activities funded by Section 317 and other funding sources. We assessed total vaccine cost and data on vaccine purchase projections for each awardee with CDC’s Cost and Affordability Tool for 2023. Results: Immunization program managers or their designees from 62 of 64 awardees (97%) completed the survey; 12 awardees participated in key informant interviews. Of 62 awardees, 32 (52%) used a single funding source to support adult vaccine purchases, of which 29 (91%) used only Section 317 funds, 21 (34%) reported not planning to purchase ≥1 age-based recommended vaccine for adults in 2023, and 33 (53%) reported using Section 317 funds only to support adult immunization program operations. Key informant interviews showed varied operational activities among awardees, but 8 awardees stated the need for additional staff to expand adult immunization program services in health care provider education (n = 5), program administration (n = 5), and site visits (n = 6). Conclusions: Additional efforts are needed to understand how to better support routine adult immunization activities implemented at the jurisdictional level.
- 19 March 2024
- Published by SAGE Publications in Public Health Reports®
- Vol. 139 (5) , 626-634
Analysis of the Federal Section 317 Immunization Program and Routine Adult Immunization Activities, United States, 2022-2023
Objectives: The federal Section 317 Immunization Program, administered by the Centers for Disease Control and Prevention (CDC), provides funding to support adult immunization efforts; however, current information on program implementation at the jurisdictional level is limited. We assessed the use of Section 317 and other funding sources to support routine adult immunization activities among the 64 immunization programs (“awardees”). Methods: We conducted a survey and key informant interviews with awardees in October to December 2022 to collect quantitative and qualitative data on current adult vaccine purchase and program operation activities funded by Section 317 and other funding sources. We assessed total vaccine cost and data on vaccine purchase projections for each awardee with CDC’s Cost and Affordability Tool for 2023. Results: Immunization program managers or their designees from 62 of 64 awardees (97%) completed the survey; 12 awardees participated in key informant interviews. Of 62 awardees, 32 (52%) used a single funding source to support adult vaccine purchases, of which 29 (91%) used only Section 317 funds, 21 (34%) reported not planning to purchase ≥1 age-based recommended vaccine for adults in 2023, and 33 (53%) reported using Section 317 funds only to support adult immunization program operations. Key informant interviews showed varied operational activities among awardees, but 8 awardees stated the need for additional staff to expand adult immunization program services in health care provider education (n = 5), program administration (n = 5), and site visits (n = 6). Conclusions: Additional efforts are needed to understand how to better support routine adult immunization activities implemented at the jurisdictional level.
- Open Access
- 7 March 2022
- Published by SAGE Publications in Health Equity
- Vol. 6 (1) , 206-223
Racial and Ethnic Disparities in Adult Vaccination: A Review of the State of Evidence
Background: Adult vaccination coverage remains low in the United States, particularly among racial and ethnic minority populations. Objective: To conduct a comprehensive literature review of research studies assessing racial and ethnic disparities in adult vaccination. Search Methods: We conducted a search of PubMed, Cochrane Library, ClinicalTrials.gov, and reference lists of relevant articles. Selection Criteria: Research studies were eligible for inclusion if they met the following criteria: (1) study based in the United States, (2) evaluated receipt of routine immunizations in adult populations, (3) used within-study comparison of race/ethnic groups, and (4) eligible for at least one author-defined PICO (patient, intervention, comparison, and outcome) question. Data Collection and Analysis: Preliminary abstract review was conducted by two authors. Following complete abstraction of articles using a standardized template, abstraction notes and determinations were reviewed by all authors; disagreements regarding article inclusion/exclusion were resolved by majority rule. The Social Ecological Model framework was used to complete a narrative review of observational studies to summarize factors associated with disparities; a systematic review was used to evaluate eligible intervention studies. Results: Ninety-five studies were included in the final analysis and summarized qualitatively within two main topic areas: (1) factors associated with documented racial-ethnic disparities in adult vaccination and (2) interventions aimed to reduce disparities or to improve vaccination coverage among racial-ethnic minority groups. Of the 12 included intervention studies, only 3 studies provided direct evidence and were of Level II, fair quality; the remaining 9 studies met the criteria for indirect evidence (Level I or II, fair or poor quality). Conclusions: A considerable amount of observational research evaluating factors associated with racial and ethnic disparities in adult vaccination is available. However, intervention studies aimed at reducing these disparities are limited, are of poor quality, and insufficiently address known reasons for low vaccination uptake among racial and ethnic minority adults.
- 7 March 2022
- Published by SAGE Publications in Health Equity
- Vol. 6 (1) , 206-223
Open AccessRacial and Ethnic Disparities in Adult Vaccination: A Review of the State of Evidence
Background: Adult vaccination coverage remains low in the United States, particularly among racial and ethnic minority populations. Objective: To conduct a comprehensive literature review of research studies assessing racial and ethnic disparities in adult vaccination. Search Methods: We conducted a search of PubMed, Cochrane Library, ClinicalTrials.gov, and reference lists of relevant articles. Selection Criteria: Research studies were eligible for inclusion if they met the following criteria: (1) study based in the United States, (2) evaluated receipt of routine immunizations in adult populations, (3) used within-study comparison of race/ethnic groups, and (4) eligible for at least one author-defined PICO (patient, intervention, comparison, and outcome) question. Data Collection and Analysis: Preliminary abstract review was conducted by two authors. Following complete abstraction of articles using a standardized template, abstraction notes and determinations were reviewed by all authors; disagreements regarding article inclusion/exclusion were resolved by majority rule. The Social Ecological Model framework was used to complete a narrative review of observational studies to summarize factors associated with disparities; a systematic review was used to evaluate eligible intervention studies. Results: Ninety-five studies were included in the final analysis and summarized qualitatively within two main topic areas: (1) factors associated with documented racial-ethnic disparities in adult vaccination and (2) interventions aimed to reduce disparities or to improve vaccination coverage among racial-ethnic minority groups. Of the 12 included intervention studies, only 3 studies provided direct evidence and were of Level II, fair quality; the remaining 9 studies met the criteria for indirect evidence (Level I or II, fair or poor quality). Conclusions: A considerable amount of observational research evaluating factors associated with racial and ethnic disparities in adult vaccination is available. However, intervention studies aimed at reducing these disparities are limited, are of poor quality, and insufficiently address known reasons for low vaccination uptake among racial and ethnic minority adults.
- 1 May 2021
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 60 (5) , 692-700
Availability of Adult Vaccination Services by Provider Type and Setting
- 1 May 2021
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 60 (5) , 692-700
Availability of Adult Vaccination Services by Provider Type and Setting
- Open Access
- 1 April 2020
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 3 (4) , e203316
State Policies on Access to Vaccination Services for Low-Income Adults
Medicaid traditionally provides health insurance to low-income children and parents, pregnant women, the elderly, and disabled individuals at little to no cost. In 2010, the Patient Protection and Affordable Care Act extended Medicaid eligibility to include childless adults with incomes up to 138% of the federal poverty level.1 Enrollment rapidly increased; by 2017, adults enrolling under this expansion made up 19.4% of the total Medicaid population.2 Medicaid currently provides health insurance to an estimated 37.5 million adults across all eligibility groups in the United States.3
- 1 April 2020
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 3 (4) , e203316
Open AccessState Policies on Access to Vaccination Services for Low-Income Adults
Medicaid traditionally provides health insurance to low-income children and parents, pregnant women, the elderly, and disabled individuals at little to no cost. In 2010, the Patient Protection and Affordable Care Act extended Medicaid eligibility to include childless adults with incomes up to 138% of the federal poverty level.1 Enrollment rapidly increased; by 2017, adults enrolling under this expansion made up 19.4% of the total Medicaid population.2 Medicaid currently provides health insurance to an estimated 37.5 million adults across all eligibility groups in the United States.3